{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:13:13Z","timestamp":1790712793743,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1186","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Approximately 60% of patients with small cell lung cancer (SCLC) develop brain metastases (BM). Historically these have been managed with whole brain radiotherapy. We sought to compare outcomes with the FIRE-SCLC study which provided a benchmark median overall survival of 8.5 months (m).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of a prospectively collected dataset of patients with SCLC receiving stereotactic radiosurgery (SRS) for BM at our center from May 2016 to October 2024. The primary objective was mOS. Survival analysis was calculated from time of first SRS to death, performed on Prism 10.1.1. Extraction from electronic medical records was undertaken by authors, with local R&amp;D approval.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty patients were evaluable and 20% of patients (N\u2009=\u20098\/40) received multiple treatments. The median follow-up time was 8.7\u2009m. The median OS was 10.0\u2009m. mOS of patients with 1 lesion was 13.8\u2009m, vs. 8.4 m and 8.7\u2009m for 2-4 and 5-10 BM. mOS for patients with KPS \u2009\u2265 \u200990 was 12.4\u2009m vs. 8.7\u2009m for those with KPS \u2264\u2009 80 (HR 1.63, P\u2009=\u2009.15). There was one death within 28\u2009days of SRS. Five patients died within 90\u2009days of SRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Median OS in this cohort of patients with SCLC BM compared favorably to the FIRE-SCLC cohort, supporting consideration in selected patients. Our cohort was limited by sample size. Further prospective research is needed to guide local therapies in ES-SCLC BM, particularly regarding adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Advances in knowledge<\/jats:title>\n                    <jats:p>UK real-world data demonstrates survival outcomes with SRS for SCLC BM comparable to FIRE-SCLC, supporting feasibility under NHS commissioning criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjr\/tqag135","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:52:55Z","timestamp":1780537975000},"page":"2148-2154","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience"],"prefix":"10.1093","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-3464","authenticated-orcid":false,"given":"David John","family":"McMahon","sequence":"first","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexius","family":"John","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanika","family":"Ketpueak","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]},{"name":"Division of Oncology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-7926","authenticated-orcid":false,"given":"James","family":"De Boisanger","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishani","family":"Sachdeva","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brewer","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Aykac","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Yu","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Nangendo","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Kalofonou","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Milner-Watts","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Sutton, Surrey SM25PT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Yousaf","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Davidson","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Sutton, Surrey SM25PT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishree","family":"Bhosle","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Sutton, Surrey SM25PT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Minchom","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Sutton, Surrey SM25PT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Sutton, Surrey SM25PT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Popat","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Welsh","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Creak","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Solda","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Taylor","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Konadu","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadza","family":"Tokaca","sequence":"additional","affiliation":[{"name":"Lung Unit, Royal Marsden Hospital , Chelsea, London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-4815","authenticated-orcid":false,"given":"Nicola","family":"Rosenfelder","sequence":"additional","affiliation":[{"name":"Neurooncology Unit, Royal Marsden Hospital , London SW36JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026092915464259600_tqag135-B1","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026092915464259600_tqag135-B2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"key":"2026092915464259600_tqag135-B3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/JAMAONCOL.2020.1271","article-title":"Evaluation of first-line radiosurgery vs. whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"2026092915464259600_tqag135-B4","doi-asserted-by":"publisher","first-page":"71223","DOI":"10.18632\/ONCOTARGET.19333","article-title":"State-of-the-art considerations in small cell lung cancer brain metastases","volume":"8","author":"Lukas","year":"2017","journal-title":"Oncotarget"},{"key":"2026092915464259600_tqag135-B5","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/JAMA.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"2026092915464259600_tqag135-B6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026092915464259600_tqag135-B7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026092915464259600_tqag135-B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/J.LUNGCAN.2018.03.027","article-title":"Radiosurgery alone is associated with favorable outcomes for brain metastases from small cell lung cancer","volume":"120","author":"Robin","year":"2018","journal-title":"Lung Cancer"},{"key":"2026092915464259600_tqag135-B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/S12885-015-1103-6","article-title":"Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients","volume":"15","author":"Yomo","year":"2015","journal-title":"BMC Cancer"},{"key":"2026092915464259600_tqag135-B10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3171\/JNS.2002.97.SUPPLEMENT","article-title":"Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma","volume":"97","author":"Serizawa","year":"2002","journal-title":"J Neurosurg"},{"key":"2026092915464259600_tqag135-B11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1470-2045(22)00271-6","article-title":"Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis","volume":"23","author":"Gaebe","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026092915464259600_tqag135-B12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026092915464259600_tqag135-B13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMOA071780","volume-title":"N Engl J Med","author":"Slotman","year":"2007"},{"key":"2026092915464259600_tqag135-B14","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.21037\/JTD.2017.10.10","article-title":"Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?","volume":"9","author":"Pechoux","year":"2017","journal-title":"J Thorac Dis"},{"key":"2026092915464259600_tqag135-B15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.5603\/RPOR.97432","article-title":"What is the current role of prophylactic cranial irradiation in the treatment algorithm for small cell lung cancer?","volume":"28","author":"Vojt\u00ed\u0161ek","year":"2023","journal-title":"Rep Pract Oncol Radiother"},{"key":"2026092915464259600_tqag135-B16","doi-asserted-by":"publisher","first-page":"107993","DOI":"10.1016\/J.LUNGCAN.2024.107993","article-title":"PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients","volume":"198","author":"Levy","year":"2024","journal-title":"Lung Cancer"},{"key":"2026092915464259600_tqag135-B17","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1200\/JCO.2017.77.5817","article-title":"Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: a randomized phase III NVALT11\/DLCRG-02 study","volume":"36","author":"De Ruysscher","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026092915464259600_tqag135-B18","first-page":"2986","volume-title":"J Clin Oncol.","year":"2025"},{"key":"2026092915464259600_tqag135-B19","doi-asserted-by":"publisher","first-page":"100408","DOI":"10.1016\/j.esmoop.2022.100408","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN","volume":"7","author":"Paz-Ares","year":"2022","journal-title":"ESMO Open"},{"key":"2026092915464259600_tqag135-B20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMOA1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"2026092915464259600_tqag135-B21","volume-title":"Overview. Atezolizumab with Carboplatin and Etoposide for Untreated Extensive-Stage Small-Cell Lung Cancer. Guidance"},{"key":"2026092915464259600_tqag135-B22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/J.CLON.2024.01.037","article-title":"Predicting survival with brain metastases in the stereotactic radiosurgery era: are existing prognostic scores still relevant? Or can we do better?","volume":"36","author":"Fittall","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2026092915464259600_tqag135-B23","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1200\/JCO.2024.42.16_SUPPL.2020","article-title":"Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: a multi-institutional, phase II, prospective clinical trial","volume":"42","author":"Aizer","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026092915464259600_tqag135-B24","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/CURRONCOL31060228","article-title":"Survival after stereotactic radiosurgery in the era of targeted therapy: number of metastases no longer matters","volume":"31","author":"de Boisanger","year":"2024","journal-title":"Curr Oncol"},{"key":"2026092915464259600_tqag135-B25","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41467-024-47998-8","article-title":"Response of treatment-naive brain metastases to stereotactic radiosurgery","volume":"15","author":"Ene","year":"2024","journal-title":"Nat Commun"},{"key":"2026092915464259600_tqag135-B26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3857\/roj.2015.33.3.207","article-title":"Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer","volume":"33","author":"Won","year":"2015","journal-title":"Radiat Oncol J"},{"key":"2026092915464259600_tqag135-B27","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1200\/JCO.2000.18.19.3400","article-title":"Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy\u2014a phase III study of the European organization for the research and treatment of cancer lung cancer cooperative group","volume":"18","author":"Postmus","year":"2000","journal-title":"J Clin Oncol"},{"key":"2026092915464259600_tqag135-B28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026092915464259600_tqag135-B29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/JNCI\/DJAD073","article-title":"Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)","volume":"115","author":"Rusthoven","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"2026092915464259600_tqag135-B30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S11060-016-2216-8","article-title":"Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)","volume":"130","author":"Berghoff","year":"2016","journal-title":"J Neurooncol"},{"key":"2026092915464259600_tqag135-B31","doi-asserted-by":"publisher","first-page":"107924","DOI":"10.1016\/J.LUNGCAN.2024.107924","article-title":"Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the phase III IMpower133 study and the phase III IMbrella A extension study","volume":"196","author":"Reck","year":"2024","journal-title":"Lung Cancer"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqag135\/68465421\/tqag135.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2148\/68465421\/tqag135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2148\/68465421\/tqag135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:46:49Z","timestamp":1790711209000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/99\/1186\/2148\/8701109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":31,"journal-issue":{"issue":"1186","published-online":{"date-parts":[[2026,6,3]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqag135","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,6,3]]}}}